The role of the sulfaguanidine molecular scaffold in drug design and development
- 10 December 2024
- journal article
- review article
- Published by Wiley in Archiv der Pharmazie
- Vol. 358 (1) , e2400802
Abstract
Developing new molecular entities is one of the most emerging research areas in the field of Medicinal Chemistry. Over the past few years, rigorous research has been conducted on sulfaguanidine‐linked synthetic molecules because of their promising potential in several biological activities. Sulfaguanidine has been actively incorporated in the design of anticancer, antimicrobial, antidiabetic, antiparkinsonian, anti‐inflammatory, and antiviral candidates. The construction of these effective candidates has adopted many chemical approaches. A number of the prepared compounds displayed promising results that merit further investigations for the development of new medications. This review summarizes the different chemical strategies and the reported activities for sulfaguanidine‐linked synthetic molecules throughout 2020–2024.Keywords
This publication has 41 references indexed in Scilit:
- Synthesis and Carbonic Anhydrase I, II, IX, and XII Inhibition Studies with a Series of Cyclic Sulfonyl GuanidinesChemMedChem, 2024
- Design and Synthesis of Pyrazole Carboxamide Derivatives as Selective Cholinesterase and Carbonic Anhydrase Inhibitors: Molecular Docking and Biological EvaluationChemistry & Biodiversity, 2024
- Exploring the potency of diazo‐coumarin containing hybrid molecules: Selective inhibition of tumor‐associated carbonic anhydrase isoforms IX and XIIChemMedChem, 2024
- Synthesis and Characterization of Novel 1,3‐Diaryltriazene‐Substituted Sulfaguanidine Derivatives as Selective Carbonic Anhydrase Inhibitors: Biological Evaluation, in Silico ADME/T and Molecular Docking StudyChemistry & Biodiversity, 2023
- Inhibition Studies on Carbonic Anhydrase Isoforms I, II, IX, and XII with a Series of SulfaguanidinesChemMedChem, 2023
- Synthesis, Characterization, and Inhibition Study of Novel Substituted Phenylureido Sulfaguanidine Derivatives as α‐Glycosidase and Cholinesterase InhibitorsChemistry & Biodiversity, 2021
- Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone‐based benzenesulfonamidesArchiv der Pharmazie, 2020
- Synthesis of benzamide derivatives with thiourea‐substituted benzenesulfonamides as carbonic anhydrase inhibitorsArchiv der Pharmazie, 2020
- Novel 1,2,4‐triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studiesArchiv der Pharmazie, 2020
- Exploring MDR‐TB Inhibitory Potential of 4‐Aminoquinazolines as Mycobacterium tuberculosis N‐Acetylglucosamine‐1‐Phosphate Uridyltransferase (GlmUMTB) InhibitorsChemistry & Biodiversity, 2020